Journal of the American Medical Association

The Journal of the American Medical Association (JAMA) is a weekly, peer-reviewed, medical journal, published by the American Medical Association. Beginning in July 2011, the editor in chief will be Howard C. Bauchner, vice chairman of pediatrics at Boston University’s School of Medicine, replacing Catherine D. DeAngelis, who has served since 2000. In 1883, the first editor was Nathan Smith Davis (1817–1904). From 1883–1960, this journal was listed with ISSN 0002-9955 and without the acronym JAMA. Furthermore, there are French and Spanish language editions of JAMA. Established in 1883 by the American Medical Association and published continuously since then, JAMA publishes original research, reviews, commentaries, editorials, essays, medical news, correspondence, and ancillary content (such as abstracts of the Morbidity and Mortality Weekly Report). The journal covers a variety of medical topics. It includes fundamental research, research for the clinical sciences, and informs physicians of developments in other fields. Issues pertaining to medicine and health care are debated in this journal. Broader topical coverage related to medicine, includes nonclinical aspects of medicine,

Publisher
American Medical Association
Country
United States
History
1883–present
Impact factor
28.899 (2009)
Some content from Wikipedia, licensed under CC BY-SA

Sex, gender, or both in medical research

No one can deny that men and women have different genes, biology and anatomical features. However, only a minority of medical studies take this into account when analyzing and reporting research results. Time to hold researchers ...

Nov 22, 2016
popularity0 comments 0

Elephants provide big clue in fight against cancer

Carlo Maley spends his time pondering pachyderms—and cactuses and whales, and a wide array of non-human species—all in pursuit of the answer to this question: Why do some life forms get cancer while others do not?

Oct 09, 2015
popularity258 comments 2

AHA: Evolocumab can help substantially reduce LDL

(HealthDay)—Combining statins with the PCSK9 inhibitor evolocumab can help reduce low-density lipoprotein (LDL) cholesterol to previously unseen levels, according to a study published online Nov. 15 in the Journal of the ...

Nov 16, 2016
popularity1 comments 0